These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26424621)

  • 1. Malaria Chemoprophylaxis and Self-Reported Impact on Ability to Work: Mefloquine Versus Doxycycline.
    Terrell AG; Forde ME; Firth R; Ross DA
    J Travel Med; 2015; 22(6):383-8. PubMed ID: 26424621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response: Malaria chemoprophylaxis and self-reported impact on ability to work.
    Terrell AG; Forde ME; Firth R; Ross DA
    J Travel Med; 2016 Feb; 23(2):tav029. PubMed ID: 26883925
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.
    Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G
    Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mefloquine and doxycycline malaria prophylaxis in Australian soldiers in East Timor.
    Kitchener SJ; Nasveld PE; Gregory RM; Edstein MD
    Med J Aust; 2005 Feb; 182(4):168-71. PubMed ID: 15720172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reported adverse events associated with antimalarial chemoprophylaxis in peace corps volunteers.
    Korhonen C; Peterson K; Bruder C; Jung P
    Am J Prev Med; 2007 Sep; 33(3):194-9. PubMed ID: 17826578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria protection in Sierra Leone during the Ebola outbreak 2014/15; The UK military experience with malaria chemoprophylaxis Sep 14-Feb 15.
    Tuck J; Williams J
    Travel Med Infect Dis; 2016; 14(5):471-474. PubMed ID: 27474994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to doxycycline vs. mefloquine.
    Conrad KA; Kiser WR
    Mil Med; 1997 Jun; 162(6):iii. PubMed ID: 9183154
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of mood profiles during malaria chemoprophylaxis: a randomized, double-blind, four-arm study.
    Schlagenhauf P; Johnson R; Schwartz E; Nothdurft HD; Steffen R
    J Travel Med; 2009; 16(1):42-5. PubMed ID: 19192127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial.
    Ohrt C; Richie TL; Widjaja H; Shanks GD; Fitriadi J; Fryauff DJ; Handschin J; Tang D; Sandjaja B; Tjitra E; Hadiarso L; Watt G; Wignall FS
    Ann Intern Med; 1997 Jun; 126(12):963-72. PubMed ID: 9182474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and tolerability of doxycycline and mefloquine in malaria prophylaxis of the ISAF troops in Afghanistan.
    Sonmez A; Harlak A; Kilic S; Polat Z; Hayat L; Keskin O; Dogru T; Yilmaz MI; Acikel CH; Kocar IH
    J Infect; 2005 Oct; 51(3):253-8. PubMed ID: 16230223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline vs. mefloquine.
    Conrad KA; Kiser WR
    Mil Med; 1997 Jan; 162(1):viii. PubMed ID: 9002694
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety, Tolerability, and Compliance with Long-Term Antimalarial Chemoprophylaxis in American Soldiers in Afghanistan.
    Saunders DL; Garges E; Manning JE; Bennett K; Schaffer S; Kosmowski AJ; Magill AJ
    Am J Trop Med Hyg; 2015 Sep; 93(3):584-90. PubMed ID: 26123954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis.
    Hoebe C; de Munter J; Thijs C
    Eur J Clin Pharmacol; 1997; 52(4):269-75. PubMed ID: 9248763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Italian army standpoint on malaria chemoprophylaxis.
    Peragallo MS
    Med Trop (Mars); 2001; 61(1):59-62. PubMed ID: 11584658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of gastrointestinal infections in United States soldiers receiving doxycycline or mefloquine for malaria prophylaxis.
    Arthur JD; Echeverria P; Shanks GD; Karwacki J; Bodhidatta L; Brown JE
    Am J Trop Med Hyg; 1990 Dec; 43(6):608-13. PubMed ID: 2267964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision.
    Senn N; D'Acremont V; Landry P; Genton B
    Am J Trop Med Hyg; 2007 Dec; 77(6):1010-4. PubMed ID: 18165513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adverse effects of mefloquine in deployed military personnel.
    Adshead S
    J R Nav Med Serv; 2014; 100(3):232-7. PubMed ID: 25895400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mefloquine versus doxycycline for malaria prophylaxis in intermittent exposure of Israeli Air Force aircrew in Rwanda.
    Shamiss A; Atar E; Zohar L; Cain Y
    Aviat Space Environ Med; 1996 Sep; 67(9):872-3. PubMed ID: 9025805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Questionnaire-based analysis of mefloquine chemoprophylaxis for malaria in a Japanese population.
    Matsumura T; Fujii T; Miura T; Koibuchi T; Endo T; Nakamura H; Odawara T; Iwamoto A; Nakamura T
    J Infect Chemother; 2005 Aug; 11(4):196-8. PubMed ID: 16133712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.